Yasuhiro Iwama
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine.
Journal: The Lancet. Infectious diseases
Published: August 30, 2024
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: June 05, 2024
Predictors of continuation for asenapine from real-world data in patients with schizophrenia.
Journal: Annals of general psychiatry
Published: April 02, 2024
Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2.
Journal: The Lancet. Infectious diseases
Published: January 10, 2024
Factors affecting the antimicrobial changes during treatment for acute otitis media in Japan: A retrospective cohort study using classification and regression trees (CART) analysis.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 03, 2023
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: August 30, 2023
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data.
Journal: Neuropsychopharmacology reports
Published: July 30, 2023
Long-term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow-up for 52 weeks (P06125)-Secondary publication.
Journal: Neuropsychopharmacology reports
Published: November 20, 2022
Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study.
Journal: Psychiatry and clinical neurosciences
Published: November 06, 2022
Improvement in the appropriate antimicrobial usage for treating pediatric acute otitis media in Japan: A descriptive study using nation-wide electronic medical record data.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 01, 2021
Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
Journal: Therapeutic innovation & regulatory science
Published: September 30, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026